
David C Linehan MD
Surgical Oncology (Other than Breast)
Seymour I. Schwartz Professor and Chairman, University of Rochester Medical Center
Join to View Full Profile
601 Elmwood Ave# BoxRochester, NY 14642
Phone+1 585-275-2725
Fax+1 585-275-8513
Dr. Linehan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Surgery, 1990 - 1997
University of Massachusetts Medical SchoolClass of 1990
Dartmouth CollegeB.A., Religion, 1986
Certifications & Licensure
NY State Medical License 2014 - 2028
MO State Medical License 1999 - 2015
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification Follow My Health, Jardogs, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2012, 2014, 2016-2017
Clinical Trials
- Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Start of enrollment: 2007 Jun 01
- Chemotherapy and Radiation Following Pancreatic Surgery Start of enrollment: 2002 May 01
- Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- Opioid Stewardship: Successful, Scalable, and Adaptable Departmental Opioid Reduction Program.Alexa D Melucci, Olivia Lynch, Michele Lawrence, John Bramley, Elizabeth Levatino
Journal of the American College of Surgeons. 2026-01-01 - Assessment of the National Institutes of Health Salary Cap Gap Reveals the Increasing Financial Burden of Training and Hiring Surgeon-Scientists.Juliet Emamaullee, Sarah Bangerth, Krista L Haines, Shannon Jordan, David Linehan
Annals of Surgery. 2025-09-01 - Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma.Joseph D Murphy, Gary Hannon, Bradley N Mills, Angela L Hughson, Taylor P Uccello
International Journal of Radiation Oncology, Biology, Physics. 2025-07-01
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
- Histological features and severity of oxaliplatin-induced liver injury and clinical associationsNalbantoglu I; Tan BR; Linehan DC; Gao F; Brunt EM, Journal of Digestive Diseases, 1/1/2014
- CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsZhu Y; Knolhoff BL; Meyer MA; Nywening TM; West BL; Luo J; Wang-Gillam A; Goedegebuure SP; Linehan DC; DeNardo DG, Cancer Research, 1/1/2014
Books/Book Chapters
Other
- Tumors of the Liver, Biliary Tract and Pancreas.Strasberg SM and Linehan DC, ACS Surgery Online: Principles & Practice, Souba WW, Fink MP, Jurkovich et al, Eds. WebMD, Inc.
http://www.acssurgery.com
1/1/2005
Authored Content
- Have the Recent Modifications of Operating Room Attire Policies Decreased Surgical Site Infections? A NSQIP Review of 6,517 PatientsFebruary 2018
Press Mentions
Strong Memorial Hospital Marks 100 Years as a Cornerstone of Academic MedicineJanuary 5th, 2026
Tom Golisano Announces Newly Formed Golisano Children’s Alliance, Building on University of Rochester's Golisano Children's Hospital’s Pioneering LegacyOctober 28th, 2025
Richard Schulick Tapped to Serve as UR Medicine’s First-Ever Chief Clinical OfficerOctober 17th, 2025
Grant Support
- CCR2 Blockade in Human Pancreas CancerNIH/NCI2014–Present
- Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic CancerUNIVERSITY OF ROCHESTER2021–2025
- Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunityUNIVERSITY OF ROCHESTER2013–2024
- Identification Of Prognostic Biomarkers In Pancreas CancerNational Center For Research Resources2008–2011
- Multivalent Dendritic Cell Vaccine In Pancreas CancerNational Cancer Institute2001–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









